Literature DB >> 56948

Detection of monocyte specific antigen on human acute leukaemia cells.

M A Baker, R E Falk, J Falk, M F Greaves.   

Abstract

Heteroantisera with specificity for human monocyte and macrophage antigens (HuMa) have been tested for activity against peripheral blood cells from patients with acute leukaemia. Using indirect immunofluorescence, blast cells from 25/27 patients with acute myelomonocytic leukaemia were reactive with anti-HuMa antisera, whereas blasts from 19/20 patients with acute myeloblastic leukaemia and 13/13 patients with acute lymphoblastic leukaemia were not reactive. The F(ab1)2 fragment of the antibody retained specific activity. Activity of whole serum against myelomonocytic blast cells was specifically removed by absorption with macrophages. These observations indicate that circulating blast cells from patients with acute myelomonocytic leukaemia may carry differentiation antigens characteristic of monocytes and macrophages.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56948     DOI: 10.1111/j.1365-2141.1976.tb01870.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  Recent progress in the immunological characterization of leukaemic cells.

Authors:  M F Greaves
Journal:  Blut       Date:  1977-05

2.  Partial molecular characterization of an antigenic structure associated to cells of common acute lymphocytic leukaemia (ALL).

Authors:  H Kabisch; R Arndt; H G Thiele; K Winkler; G Landbeck
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

3.  Immunologic diagnosis and monitoring of human acute leukemias: a review.

Authors:  M Maheu; M A Baker; J A Falk; R N Taub
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

4.  Expression of myeloid differentiation antigens on normal and malignant myeloid cells.

Authors:  J D Griffin; J Ritz; L M Nadler; S F Schlossman
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

5.  Further evidence of response by leukaemia patients in remission to antigen(s) related to acute myelogenous leukaemia.

Authors:  P Cocks; R L Powles; B Chapuis; P Alexander
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.